Kindly MD, Inc. (KDLY)
- Previous Close
1.0100 - Open
1.0177 - Bid 0.9832 x 100
- Ask 1.0700 x 100
- Day's Range
1.0000 - 1.0398 - 52 Week Range
1.0000 - 4.2000 - Volume
23,036 - Avg. Volume
95,817 - Market Cap (intraday)
6.143M - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-0.4100 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Kindly MD, Inc., a healthcare and healthcare data company, provides direct health care services to patients integrating prescription medicine and behavioral health services. The company offers specialty outpatient clinical services based on a subscription and fee-for-service basis to augment traditional healthcare. It provides evaluation and management services, including chronic pain, functional medicine, cognitive behavioral therapy, trauma and addiction therapy, recovery support, overdose education, peer support, limited urgent care, preventative medicine, travel, and hormone therapy; and data collection and research, and online and email campaign marketing services, as well as engages in the retail sale of health care products through clinics and online. Kindly MD, Inc. was formerly known as Utah Therapeutic Health Center, LLC and changed its name to Kindly MD, Inc. in March 2022. The company was incorporated in 2019 and is based in Salt Lake City, Utah.
kindlymd.com23
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: KDLY
View MorePerformance Overview: KDLY
Trailing total returns as of 10/4/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: KDLY
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: KDLY
View MoreValuation Measures
Market Cap
6.14M
Enterprise Value
1.85M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.98
Price/Book (mrq)
1.40
Enterprise Value/Revenue
0.60
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-78.86%
Return on Assets (ttm)
-41.58%
Return on Equity (ttm)
-113.00%
Revenue (ttm)
3.1M
Net Income Avi to Common (ttm)
-2.44M
Diluted EPS (ttm)
-0.4100
Balance Sheet and Cash Flow
Total Cash (mrq)
4.74M
Total Debt/Equity (mrq)
10.12%
Levered Free Cash Flow (ttm)
-352.56k